These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 1630695)

  • 41. A 52-week, randomized, open-label, parallel-group comparison of the tolerability and effects of pitavastatin and atorvastatin on high-density lipoprotein cholesterol levels and glucose metabolism in Japanese patients with elevated levels of low-density lipoprotein cholesterol and glucose intolerance.
    Sasaki J; Ikeda Y; Kuribayashi T; Kajiwara K; Biro S; Yamamoto K; Ageta M; Kobori S; Saikawa T; Otonari T; Kono S
    Clin Ther; 2008 Jun; 30(6):1089-101. PubMed ID: 18640465
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Hypercholesterolemia in the aged: rational approach to the problem].
    Antonicelli R; Lipponi G; Cadeddu G; Gaetti R
    Clin Ter; 1990 Aug 15-31; 134(3-4):173-80. PubMed ID: 2147617
    [TBL] [Abstract][Full Text] [Related]  

  • 43. A comparison of simvastatin and atorvastatin up to maximal recommended doses in a large multicenter randomized clinical trial.
    Illingworth DR; Crouse JR; Hunninghake DB; Davidson MH; Escobar ID; Stalenhoef AF; Paragh G; Ma PT; Liu M; Melino MR; O'Grady L; Mercuri M; Mitchel YB;
    Curr Med Res Opin; 2001; 17(1):43-50. PubMed ID: 11464446
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Simvastatin in the treatment of familial hypercholesterolemia].
    Ceska R; Sobra J; Procházková R; Kvasilová M
    Cas Lek Cesk; 1995 May; 134(10):310-3. PubMed ID: 7788650
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Long-term effects of simvastatin in hypercholesterolemic patients with NIDDM and additional atherosclerotic risk factors. Hyogo Simvastatin Study Group.
    Kazumi T; Yoshino G; Ohki A; Matsuba K; Ino T; Amano M; Kasuga M
    Horm Metab Res; 1995 May; 27(5):239-43. PubMed ID: 7642176
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Diabetes mellitus, hypercholesterolemia, and therapeutic prospects with simvastatin. General considerations and personal contribution].
    Pipicelli G; Pentimone F; Frustaci G; Notarangelo R; Beghè F
    Minerva Med; 1992 Dec; 83(12):819-25. PubMed ID: 1491762
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Effect of simvastatin in CAPD patients with hypercholesterolemia.
    De Vecchi A; Scalamogna A; Paparella M; Colombini M; Rovellini A; Pini C; Castelnovo C
    Adv Perit Dial; 1992; 8():331-3. PubMed ID: 1361817
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Bezafibrate and simvastatin (MK-733) in the treatment of primary hypercholesterolaemia.
    Smith DH; Neutel JM; Jankelow D; Myburgh DP
    S Afr Med J; 1990 May; 77(10):500-3. PubMed ID: 2188379
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Mid-term clinical study of the effectiveness of and tolerability to simvastatin ++ in dyslipidemic patients].
    Irace L; Aiello C; Papa A; Sannino A; Petraglia L; De Lucia R; Dragonetti C
    Minerva Med; 1992 Dec; 83(12):815-8. PubMed ID: 1491761
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Clinical investigation on the hypolipidemic effect of simvastatin in primary hypercholesterolemia.
    Saba P; Galeone F; Giuntoli F; Spagnolo G; Brunelleschi G; Lamanna F; Angelé B
    Clin Ter; 1992 Jan; 140(1 Pt 2):3-9. PubMed ID: 1559319
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Simvastatin in severe primary hypercholesterolemia: efficacy, safety, and tolerability in 595 patients over 18 weeks. The Principal Investigators.
    Simons LA
    Clin Cardiol; 1993 Apr; 16(4):317-22. PubMed ID: 8458112
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Simvastatin in non-insulin-dependent diabetic patients with hypercholesterolaemia.
    Steyn K; Weich HF; Bonnici F; Kotze TJ; Stander I; Vermaak WJ; Lourens W; van Lathem J; Omar MA; Fourie J
    S Afr Med J; 1992 Dec; 82(6):402-6. PubMed ID: 1465688
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Effects of long-term treatment with simvastatin on plasma lipids and lipoproteins in patients with primary hypercholesterolemia.
    Thiery J; Creutzfeldt C; Creutzfeldt W; Walli AK; Seidel D
    Klin Wochenschr; 1990 Aug; 68(16):814-22. PubMed ID: 2214604
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Significant increase of high-density lipoprotein2-cholesterol under prolonged simvastatin treatment.
    Neuman MP; Neuman HR; Neuman J
    Atherosclerosis; 1991 Dec; 91 Suppl():S11-9. PubMed ID: 1789812
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Treatment of hypercholesterolemia with the HMG CoA reductase inhibitor, simvastatin.
    Berger GM; Marais AD; Seftel HC; Baker SG; Mendelsohn D; Welsh NH; Joffe BI
    Cardiovasc Drugs Ther; 1989 Apr; 3(2):219-27. PubMed ID: 2487533
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Effects of low-dose simvastatin therapy on serum lipid levels in patients with moderate hypercholesterolemia: a 12-month study. The Simvastatin Study Group.
    Itoh T; Matsumoto M; Hougaku H; Handa N; Tsubakihara Y; Yamada Y; Imaizumi M; Hoshi M; Shimazu Y; Hori M; Kawamori R; Ueda N; Fusamoto H; Kamada T
    Clin Ther; 1997; 19(3):487-97. PubMed ID: 9220213
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [The efficacy and tolerance of simvastatin and fenofibrate in primary hypercholesterolemia].
    Fricker J; Douste-Blazy P; Drouin P; De Gennes JL; Dachet C; Keller U
    Presse Med; 1990 Dec; 19(42):1927-30. PubMed ID: 2147752
    [TBL] [Abstract][Full Text] [Related]  

  • 58. The use of simvastatin, an HMG CoA reductase inhibitor, in older patients with hypercholesterolemia and atherosclerosis.
    Bach LA; Cooper ME; O'Brien RC; Jerums G
    J Am Geriatr Soc; 1990 Jan; 38(1):10-4. PubMed ID: 2404052
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Is fat restriction needed with HMGCoA reductase inhibitor treatment?
    Clifton PM; Wight MB; Nestel PJ
    Atherosclerosis; 1992 Mar; 93(1-2):59-70. PubMed ID: 1596304
    [TBL] [Abstract][Full Text] [Related]  

  • 60. The effect of Simvastatin on the plasma antioxidant concentrations in patients with hypercholesterolaemia.
    Human JA; Ubbink JB; Jerling JJ; Delport R; Vermaak WJ; Vorster HH; Lagendijk J; Potgieter HC
    Clin Chim Acta; 1997 Jul; 263(1):67-77. PubMed ID: 9247729
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.